跳至主要内容
欧盟官方标签名称词汇表条目 14905

LAURAMIDE DEA

本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。

全球证据概览

所解析的身份在 13 个已索引市场数据集中的 0 个有匹配的监管证据:0 条国家记录和 0 条欧盟附件记录。下方列出每项结果和证据缺口。

0 个市场有证据
已检查的市场
13
有证据的市场
0
证据缺口
13
已解析的标识符
2

已解析的物质身份

CAS:120-40-1
EC:204-393-1
成分索引记录:
LAURAMIDE DEA
化妆品功能: ANTISTATIC, SURFACTANT - CLEANSING, SURFACTANT - FOAM BOOSTING, VISCOSITY CONTROLLING

N,N-bis(2-Hydroxyethyl)dodecanamide

清单限制备注: III/60

1 个匹配或报告的名称
LAURAMIDE DEA

跨市场监管证据

此处跟踪的 13 个市场均没有以 LAURAMIDE DEA 为名的已导入规则。

这是关于本清单的陈述,而非关于法律的陈述:没有已导入的规则并不能证明某物质获准使用。规则可能以其他名称存在,或以本词汇表条目未载有的 CAS 或 EC 编号存在,或存在于尚未导入的数据集中。

化学身份与性质

CAS 120-40-1 的 PubChem 二维化学结构
CAS 120-40-1PubChem CID 8430

Lauric acid diethanolamide

Lauric acid diethanolamine condensate (1/1) is an off-white waxy solid. (NTP, 1992) — CAMEO Chemicals

IUPAC 名称
N,N-bis(2-hydroxyethyl)dodecanamide
分子式
C16H33NO3
分子量
287.44 g/mol
精确质量
287.24604391 Da
XLogP3
3.5
拓扑极性表面积
60.8 Ų
氢键供体
2
氢键受体
3
共价单元
1
已定义的立体中心
0

又称

Lauric diethanolamideLauramide DEALauryl diethanolamideAlkamide LEStandamidd ldComperlan LDCondensate PLMackamide LL
另有 16 个已报告名称
DiethanollauramideHetamide MLMackamide LLMEmpilan LDEEthylan MLDLauroyldiethanolamineClindrol 100LRolamid cdLankrostat JPIncromide LRStandamid LDLauramido DEAN,N-Bis(2-hydroxyethyl)lauramideRichamide STDAminon L 02Lalmin D
外部数据库标识符

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配8430

Attributed physical-property, hazard, environmental and use annotations.

  • Boiling Point: 462 to 471 °F at 760 mmHg (NTP, 1992) 来源: CAMEO Chemicals
  • Substance: Lauric Acid Diethanolamine Condensate 来源: NTP Technical Reports
  • NTP Technical Report: TR-480: Toxicology and Carcinogenesis Studies of Lauric Acid Diethanolamine Condensate (CASRN 120-40-1) in F344/N Rats and B6C3F1 Mice (Dermal Studies) (1999 ) 来源: NTP Technical Reports
  • Peer Review Date: 12/10/97 来源: NTP Technical Reports
  • Conclusion for Male Rat: No Evidence 来源: NTP Technical Reports
  • Conclusion for Female Rat: No Evidence 来源: NTP Technical Reports
  • Conclusion for Male Mice: No Evidence 来源: NTP Technical Reports
  • Conclusion for Female Mice: Some Evidence 来源: NTP Technical Reports
  • Summary: Under the conditions of these 2-year dermal studies, there was no evidence of carcinogenic activity of lauric acid diethanolamine condensate in male or female F344/N rats administered 50 or 100 mg/kg or in male B6C3F1 mice administered 100 or 200 mg/kg. There was some evidence of carcinogenic activity in female B6C3F1 mice based on increased incidences of hepatocellular neoplasms. These increases were associated with free diethanolamine, which was present as a contaminant of lauric acid diethanolamine condensate.; Dermal administration of lauric acid diethanolamine condensate to rats and mice for 2 years resulted in increased incidences of epidermal and sebaceous gland hyperplasia, hyperkeratosis, chronic inflammation, and parakeratosis at the site of application.; Lauric acid diethanolamine condensate administration also resulted in increased incidences of thyroid gland follicular cell hyperplasia in dosed male mice. 来源: NTP Technical Reports
  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) shou 来源: CAMEO Chemicals
  • Signal: Danger 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H315 (45.4%): Causes skin irritation [Warning Skin corrosion/irritation]; H318 (93.9%): Causes serious eye damage [Danger Serious eye damage/eye irritation]; H411 (27.1%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P264, P264+P265, P273, P280, P302+P352, P305+P354+P338, P317, P321, P332+P317, P362+P364, P391, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 809 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Cosmetic Ingredient Review Conclusion: The CIR Expert Panel concluded that the following 33 diethanolamides are safe in the present practices of use and concentration described in this safety assessment when formulated to be non-irritating and when the levels of free diethanolamine in the diethanolamides do not exceed the present practices of use and concentration of diethanolamine itself. The Expert Panel cautions that ingredients should not be used in cosmetic products in which N-nitroso compounds can be formed...Lauramide DEA... 来源: Cosmetic Ingredient Review (CIR)
  • Cosmetic Ingredient Review Finding(s): Safe for use in cosmetics, with qualifications 来源: Cosmetic Ingredient Review (CIR)
  • Environmental Bioconcentration: Based upon an estimated water solubility of 226 mg/l(1), the BCF of N,N-di(2-hydroxyethyl)lauramide can be estimated to be approximately 29 from a regression-derived equation(1). Based on this BCF value, bioconcentration is not expected to be an important fate process(SRC). 来源: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: When dissolved in aqueous solutions, N,N-di(2-hydroxyethyl)lauramide will have soil mobility ranging from medium to high(3) based on estimated Koc values ranging from 52 to 221(1,2). 来源: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: N,N-Di(2-hydroxyethyl)lauramide is essentially nonvolatile from water based upon an estimated Henry's Law constant of 2.16X10-12 atm cu m/mol(1,2,SRC). In natural river water, 98% of N,N-di(2-hydroxyethyl)lauramide was biodegraded in 6 days (20 mg/l)(3). Aquatic bioconcentration and adsorption to sediment are not expected to be important fate processes(SRC). 来源: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: Based on an estimated vapor pressure of approximately 6.7X10-9 mm Hg at 25 °C(1), N,N-di(2- hydroxyethyl)lauramide will exist primarily in the particulate phase in the ambient atmosphere(2). In the vapor phase, it will degrade in the ambient atmosphere by reaction with photochemically produced hydroxyl radicals with an estimated half-life of 8 hrs(3). Physical removal of particulate N,N-di(2- hydroxyethyl)lauramide from air is likely to occur through wet and dry deposition(SRC). 来源: Hazardous Substances Data Bank (HSDB)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

进一步查看此记录

在配方中筛查打开独立对比

官方来源与范围

导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。

打开官方决定